Comparative risk of musculoskeletal adverse reactions among new users of dipeptidyl peptidase-4 inhibitors: A retrospective cohort study

Comparative risk of musculoskeletal adverse reactions among new users of dipeptidyl peptidase-4 inhibitors: A retrospective cohort study

Background: The effects of dipeptidyl peptidase-4 inhibitors (DPP4Is) on joint pain have been controversial. Objective: To assess the comparative musculoskeletal (MSk) risk of DPP4Is vs. non-DPP4Is. Methods: This study used a national claims database from January 2007 to December 2014. Exposure incl...

Full description

Bibliographic Details
Main Authors: Taehwan Park, Maureen Bresnahan, Scott K. Griggs, Jiajing Chen, Alex H. Cho, Yolene Gousse, Mark Feinglos
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Exploratory Research in Clinical and Social Pharmacy
Subjects:
DPP4 inhibitors
Comparative risk
Musculoskeletal adverse reactions
Pharmacoepidemiology
Online Access:http://www.sciencedirect.com/science/article/pii/S2667276621000226

Internet

http://www.sciencedirect.com/science/article/pii/S2667276621000226

Similar Items